TABLE 3.
BBI and CDC performance panel results for three LD WB kits and the C6 ELISAa
| Specimen(s) | IgG
|
IgM
|
IgG/IgM C6 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| RR | MB | VM | BBI | RR | MB | VM | BBI | ||
| BBI panela | |||||||||
| 202-08, 202-09 | − | − | − | − | − | − | − | − | − |
| 202-01 | − | − | − | − | + | − | + | + | + |
| 202-05, 202-07, 202-14 | − | − | − | − | + | + | + | + | + |
| 202-04 | + | − | − | − | − | − | − | − | + |
| 202-06, 202-11, 202-12, 202-13 | + | + | + | + | − | − | − | − | + |
| 202-15 | + | + | + | + | − | + | + | − | + |
| 202-02 | + | + | + | + | + | − | − | − | + |
| 202-03 | + | + | + | + | + | − | + | − | + |
| 202-10 | + | + | + | + | + | − | + | + | + |
| CDC panelb | |||||||||
| 90-0875, 90-0876, 90-0877, 90-2631, 91-1458, 93-0208 | − | − | − | − | − | − | − | − | − |
| 90-0874, 90-0878, 91-1845 | − | − | − | − | − | − | + | − | − |
| 91-1352, 91-1846, 92-1682 | − | − | − | − | − | − | − | − | + |
| 91-1354 | − | − | − | − | − | − | + | − | + |
| 91-1350, 91-1843 | − | − | − | − | + | − | + | + | + |
| 91-1104, 91-1347, 91-1349, 92-1941, 91-1841, 91-1847 | − | − | − | − | + | + | + | + | + |
| 91-1351 | − | − | + | − | + | − | + | + | + |
| 91-1353 | − | − | + | − | + | + | + | + | + |
| 91-1222 | − | + | + | + | + | + | + | + | + |
| 91-0521 | + | + | − | + | − | − | − | − | + |
| 91-1842 | + | − | − | − | − | − | − | − | + |
| 93-1426 | + | − | + | − | − | − | + | − | + |
| 93-1414 | + | − | − | − | + | + | + | + | + |
| 91-0544 | + | + | + | + | + | − | − | − | + |
| 91-0865, 92-0057 | + | + | + | + | + | + | − | − | + |
| 90-2111, 91-0794, 91-0531, 91-0532, 91-0900, 91-0943 | + | + | + | + | − | − | − | − | + |
| 90-2436 | + | + | + | + | − | − | + | − | + |
| 91-1348 | + | + | + | + | + | − | + | + | + |
| 91-1844 | + | + | + | + | + | − | + | + | + |
| 90-2668 | + | + | + | − | + | + | + | + | + |
| 91-0533 | + | + | + | + | + | + | + | − | + |
a
Abbreviations: RR, reference result provided with panel; MB, Marblot; VM, Virablot; BBI, BBI WB; C6, C6 ELISA.
b
For specimens in the BBI panel, the percentages of positive results were as follows: in the IgG RR, MB, VM, and BBI, 60, 53, 53, and 53%, respectively; in the IgM RR, MB, VM, and BBI, 47, 27, 47, and 33%, respectively; in the C6, 87%.
c
For specimens in the CDC panel, the percentages of positive results were as follows: in the IgG RR, MB, VM, and BBI, 43, 38, 43, and 36%, respectively; in the IgM RR, MB, VM, and BBI, 45, 31, 52, and 36%, respectively; in the C6, 79%.